Skip to main content

Breadcrumb

  1. Home

Submission Tool and Repository Measure Database

As the Centers for Medicare & Medicaid Services (CMS) consensus-based entity (CBE), Battelle Memorial Institute (Battelle) discloses complete information (e.g., full measure specifications, coding logic, algorithms) regarding each measure to the public for the purpose of evaluating, analyzing, or displaying of each measure for endorsement consideration. If an interested party wishes to attain complete measure information for the use and/or implementation of a measure, the interested party should contact the measure steward. Contact information for the measure steward can be found under the “Point of Contact” section of the respective measure page within the Submission Tool and Repository (STAR). Battelle is not responsible for, nor is privy to the measure use agreements that may be established between a measure steward and an interested party.

To obtain a copy of the full measure submission forms for measures endorsed prior to Fall 2022 cycle, please contact [email protected].

No Filters Selected
          CBE ID Sort descending Title Steward Endorsement Cycle Status Date of Last Endorsement Decision
          0070 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) American College of Cardiology Endorsed
          0070e Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) American College of Cardiology Endorsed
          0071 Persistence of Beta-Blocker Treatment After a Heart Attack National Committee for Quality Assurance Endorsed
          0072 CAD: Beta-Blocker Treatment after a Heart Attack National Committee for Quality Assurance Endorsement Removed
          0073 Ischemic Vascular Disease (IVD): Blood Pressure Control National Committee for Quality Assurance Endorsement Removed
          0074 Chronic Stable Coronary Artery Disease: Lipid Control American College of Cardiology Endorsement Removed
          0075 Ischemic Vascular Disease (IVD): Complete Lipid Profile and LDL-C Control <100 mg/dL National Committee for Quality Assurance Endorsement Removed
          0076 Optimal Vascular Care (Composite) MN Community Measurement
          0077 Heart Failure: Symptom and Activity Assessment Physician Consortium for Performance Improvement Endorsement Removed
          0078 Heart Failure (HF) : Assessment of Clinical Symptoms of Volume Overload (Excess) Physician Consortium for Performance Improvement Endorsement Removed